INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,566 Cr | ₹1,581 Cr | ₹1,383 Cr | ₹1,215 Cr | ₹1,023 Cr |
What is the latest Total Expenditure of INDOCO REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹1,566 Cr |
| Mar2024 | ₹1,581 Cr |
| Mar2023 | ₹1,383 Cr |
| Mar2022 | ₹1,215 Cr |
| Mar2021 | ₹1,023 Cr |
How is Total Expenditure of INDOCO REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,566 Cr | -0.96 | |
| Mar2024 | ₹1,581 Cr | 14.34 | |
| Mar2023 | ₹1,383 Cr | 13.84 | |
| Mar2022 | ₹1,215 Cr | 18.70 | |
| Mar2021 | ₹1,023 Cr | - | |
Compare Total Expenditure of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,083.7 Cr | 3.1% | -5% | -22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 3.1% |
-5% |
-22.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses